Skip to main content

Day: September 14, 2020

Hudson Technologies Names Kenneth Gaglione Vice President – Operations

PEARL RIVER, N.Y., Sept. 14, 2020 (GLOBE NEWSWIRE) — Hudson Technologies, Inc. (NASDAQ: HDSN) (the “Company”) today announced the appointment of Kenneth Gaglione to the Company’s newly created role of Vice President – Operations.  Mr. Gaglione most recently served as Global Marketing Director for aftermarket refrigerants at Honeywell International, Fluorine Products group.Mr. Gaglione has nearly thirty years’ experience in marketing and sales in various industries within the public and private sectors, both developing new markets and managing growth of mature businesses.  At Honeywell, his primary focus was the refrigerant sector where he was responsible for the profitable growth of the global aftermarket business including product management, demand planning, pricing strategy, process efficiency and new product commercialization....

Continue reading

MariMed To Commence Adult-Use Operations at Panacea Wellness Dispensary in Middleborough, Massachusetts

NORWOOD, Mass., Sept. 14, 2020 (GLOBE NEWSWIRE) — MariMed Inc. (MRMD:OTCQX) (the “Company” or “MariMed”), a leading multi-state cannabis and hemp operator focused on health and wellness, today announced that the Massachusetts Cannabis Control Commission (“CCC”) completed its final inspection and has authorized MariMed’s Panacea Wellness Dispensary in Middleborough, Massachusetts to commence adult-use retail sales which it has scheduled to begin on Monday, September 14th.Panacea Wellness has been open under the Massachusetts Medical Cannabis Program since December of last year. Panacea Wellness will now be open to sell cannabis flowers and products to all customers over 21 years of age in compliance with the Massachusetts Adult Use Cannabis Program. Entry into the adult-use market significantly expands MariMed’s addressable market...

Continue reading

Collectors Universe Announces Board Refreshment

Expands Board to Eight Members with Appointments of Kate W. Duchene, Vina M. Leite and Jon M. SullivanAddition of Three New Independent Directors Further Strengthens Board and Enhances Independent Oversight and DiversityNEWPORT BEACH, Calif., Sept. 14, 2020 (GLOBE NEWSWIRE) — Collectors Universe, Inc. (NASDAQ: CLCT), a leading provider of value-added authentication and grading services to dealers and collectors of collectibles, today announced that its Board of Directors has implemented a significant refreshment through the appointment of three new, highly qualified independent directors. The new directors have been appointed effective immediately, expanding the Collectors Universe Board from five to eight members, seven of whom are independent. The new directors are:Kate W. Duchene, Chief Executive Officer of RGP, a publicly traded...

Continue reading

Willow Biosciences Inc. to Webcast Live at Life Sciences Investor Forum September 17th   

VANCOUVER, British Columbia, Sept. 14, 2020 (GLOBE NEWSWIRE) — Willow Biosciences Inc. (TSX: WLLW, OTCQX: CANSF), based in Vancouver, Canada, focused on manufacturing pharmaceutical grade quality cannabinoids via synthetic biology, today announced that Trevor Peters, President and Chief Executive Officer, will present live at LifeSciencesInvestorForum.com on September 17th.  DATE: Thursday, September 17thTIME: 2:30 PM ETLINK: https://bit.ly/30GjErkThis will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates.Learn...

Continue reading

Open Lending Signs Sound Credit Union to Lenders Protection™ Program

AUSTIN, Texas, Sept. 14, 2020 (GLOBE NEWSWIRE) — Open Lending Corporation (NASDAQ: LPRO), a leading provider of loan analytics, risk-based pricing, risk modeling and default insurance to auto lenders throughout the United States, today announced that Sound Credit Union (Sound), a $2.1 billion institution based in Tacoma, WA, has signed with Open Lending to implement their Lenders Protection™ program.Since its establishment in 1940, Sound has been dedicated to its members financial well-being by providing quality products and services. Senior Vice President, Chief Lending Officer, Lyman Williams, explains, “At Sound, our purpose is to stand with you through all waves of life. Our partnership with Open Lending allows us to offer our membership auto loans with reasonable interest rates. Lenders Protection™ will be a great resource that...

Continue reading

Nuvo Pharmaceuticals® to Webcast Live at Life Sciences Investor Forum September 17th

– Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on LifeSciencesInvestorForum.com –MISSISSAUGA, Ontario, Sept. 14, 2020 (GLOBE NEWSWIRE) — Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products, today announced Jesse Ledger, Nuvo’s President & Chief Executive Officer and Kelly Demerino, Nuvo’s Interim Chief Financial Officer will present live at LifeSciencesInvestorForum.com on September 17th.This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast...

Continue reading

Non-Invasive Prenatal Testing Market to Reach $10.88 Billion by 2027; Technological Intervention has Played a Massive Role in Market Growth, says Fortune Business Insights™

Pune, Sept. 14, 2020 (GLOBE NEWSWIRE) — The global Non-Invasive Prenatal Testing market size is projected to reach USD 10.88 billion by the end of 2027. The presence of several large scale companies will have a positive impact on the growth of the market in the coming years.According to a report published by Fortune Business Insights, titled “Non-Invasive Prenatal Testing (NIPT) Market Size, Share & COVID-19 Impact Analysis, By Product (Instruments, and Consumables & Reagents), Technology (Next Generation Sequencing, Microarray, PCR, and Rolling Circular Amplification), End User (Hospitals, and Clinical Laboratories) Regional Forecast, 2020-2027,” the market was worth USD 2.95 billion in 2019 and will exhibit a CAGR of 17.8% during the forecast period, 2020-2027.Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/non-invasive-prenatal-testing-market-100998Non-Invasive...

Continue reading

XP Inc. Reduces Pricing for Online Trading by Eliminating Stock Brokerage Fees at Rico and Reducing XP Direct Fees by 75%

SÃO PAULO, Brazil, Sept. 14, 2020 (GLOBE NEWSWIRE) — XP Inc. (Nasdaq: XP), a leading, technology-driven financial services platform and a trusted provider of low-fee financial products and services in Brazil, announced the elimination of brokerage fees for online stock trades at Rico, our online-only solution for self-directed investors, and a reduction of 75% at XP Direct (B2C) for the same type of trades.Guilherme Benchimol, XP’s founder and CEO commented, “democratizing investments in Brazil has been the company’s core mission since its inception in 2001. Brazilians are in the early stages of an unprecedented opportunity to diversify their investments and shift allocations, which are still concentrated in high-fee fixed income products. Our decision to reduce online brokerage fees at Rico and XP Direct is aimed at lowering barriers...

Continue reading

Supernus Submits NDA for SPN-830 for Continuous Treatment of ON-OFF Episodes in Adults with Parkinson’s Disease Who Have Failed Two Treatments

ROCKVILLE, Md., Sept. 14, 2020 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its apomorphine infusion pump (SPN-830) for the continuous treatment of ON-OFF episodes in adults with Parkinson’s disease (PD) whose motor control is unsatisfactory with oral levodopa and at least one other noninvasive PD therapy.“We believe the continuous treatment of “OFF” episodes may offer PD patients an important alternative over currently available acute treatments,” said Jack Khattar, President and CEO of Supernus. “Current alternatives to acute treatment often require continuous...

Continue reading

Novo Settles Millennium Minerals Limited’s Debt to IMC

VANCOUVER, British Columbia, Sept. 14, 2020 (GLOBE NEWSWIRE) — Novo Resources Corp. (“Novo” or the “Company”) (TSX-V: NVO; OTCQX: NSRPF) is pleased to announce that Novo’s recently acquired wholly-owned subsidiary, Millennium Minerals Limited (“Millennium”), has today settled all debts (the “Debt Settlement”) it owed to IMC Resources Gold Holdings Pte Ltd and IMC Resources Investments Pte Ltd (collectively, “IMC”). Please see the Company’s news releases dated August 4, 2020, and September 8, 2020 for further details.All amounts are in United States dollars unless indicated otherwise.Millennium has repaid IMC’s secured debt of approximately $50.3 million (A$69 million) by way of payment of $43.7 million (A$60 million) in cash and the balance by procuring the issuance by Novo of 2,656,591 units of Novo (each a “Unit”) issued to IMC...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.